NPM1 and acute myeloid leukemia: Since the earliest observations, the rare finding of NPM1 mutations in MNs with <20% blasts in small and mainly retrospective series, has been commonly associated with an aggressive clinical course and relatively rapid progression to overt AML, usually within 12 months since diagnosis, as detailed in Table 3 [5,40,45,46,62,69,71,75].